We solely use the strain Cannabis Sativa L., commonly known as industrial hemp, is a plant with allowed amount of THC being less than 0.2% according to the EU regulation 1307/2013. In our products we solely use Italian grown Cannabis Sativa L., variety Futura 75 which are listed in the European common catalogue of varieties of agricultural plant species in accordance with Article 17 of Council Directive 2002/53/EC of 13 June 2002. As our Cannabis sativa L. are specifically cultivated to have a high CBD content and comply with EU regulations, it contains little-to-no traces of THC. If there is any THC traces present, it is not enough to exhibit psychoactive effects to make people high.
Specialized in developing medical devices with CBD, innovative treatment solutions, and skincare with natural Cannabidiol (CBD).
The 3 cores of CanNordic: Intellectual property, Optimized Delivery System Technology and Regulatory Compliance and Certifications
Medical devices and selected products have patent pending in accordance with Patent Cooperation Treaty (PCT) covering 153 nations across the globe
Other patents include
Anti-Hair Loss Serum and Supplements
TRADEMARK IN ACCORDANCE TO PCT
CANNASEN® trademark registered
Increased bioavailability of cannabinoids through topical or intranasal use, optimizing the overall impact and efficacy of CBD and other cannabinoids
We focus on delivering product that comply with technical requirements to make sure that our customers benefit from compliance with high market standards of efficacy, quality and safety.
CE classified medical devices – quality assured and tested in compliance with the European Medical Devices Directive (MDD).
Cultivation, sowing, harvesting, and extracting of the cannabinoids used in all medical devices and cosmetic products and are handled in cooperation with leading partners in each process of the production of CANNASEN® CBD.
